Gilead

  • Column: Five Reasons the Gilead Deal is a Steaming Pile of Truvada

    Gilead Sciences, the pharmaceutical company that makes Truvada, the only FDA-approved drug for PrEP, is having a great week in the public relations department. First, Gilead announced they were surrendering their patent for Truvada a year early, and now federal officials have announced that Gilead will donate enough Truvada for 200,000 people in the United States.

  • Gilead Hit With More Lawsuits Over Harmful Side Effects of AIDS Drug

    (WB) Another two lawsuits were filed last week in California against the U.S. pharmaceutical company Gilead Sciences, Inc. by several dozen patients who claim the company withheld from the market for more than a decade a drug for treating HIV that it knew was safer and more effective than the drug it promoted during that period.